NCT06474091View on ClinicalTrials.gov

Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)

Enrolling by invitationOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

May 8, 2029

Study Completion Date

May 8, 2029

Conditions
Cholangiocarcinoma
Interventions
OTHER

Non-Interventional Study

Non-Interventional Study

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER